Autoimmune neutropenia
| Autoimmune neutropenia | |
|---|---|
| Synonyms | Primary autoimmune neutropenia, Immune neutropenia |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Neutropenia, increased risk of infection |
| Complications | Bacterial infection, sepsis |
| Onset | Typically in infancy or early childhood |
| Duration | Variable, often resolves spontaneously |
| Types | N/A |
| Causes | Autoimmune disorder |
| Risks | Family history of autoimmune diseases |
| Diagnosis | Complete blood count, antineutrophil antibody test |
| Differential diagnosis | Congenital neutropenia, cyclic neutropenia, drug-induced neutropenia |
| Prevention | N/A |
| Treatment | Granulocyte colony-stimulating factor, immunoglobulin therapy, corticosteroids |
| Medication | N/A |
| Prognosis | Generally good, especially in children |
| Frequency | Rare |
| Deaths | N/A |
Autoimmune neutropenia (AIN) is a rare disorder characterized by the body's immune system attacking and destroying neutrophils, which are a type of white blood cell essential for fighting off infections. This condition can occur in both adults and children, but it is most commonly observed in infants and young children. The exact cause of AIN is not fully understood, but it is believed to be related to an abnormal immune response.
Etiology[edit]
Autoimmune neutropenia can be classified into primary and secondary forms. Primary autoimmune neutropenia is idiopathic, meaning its exact cause is unknown. It is thought to occur when the immune system mistakenly targets neutrophils as foreign and creates antibodies against them. Secondary autoimmune neutropenia is associated with other autoimmune disorders, such as rheumatoid arthritis, systemic lupus erythematosus, and Crohn's disease, or with certain medications that alter the immune system's function.
Pathophysiology[edit]
In autoimmune neutropenia, autoantibodies target and bind to neutrophils. This leads to the premature destruction of these cells by the spleen and other parts of the immune system. The reduction in neutrophil count, known as neutropenia, makes individuals more susceptible to infections.
Clinical Manifestations[edit]
The primary symptom of autoimmune neutropenia is an increased susceptibility to infections. These infections are typically mild and may include conditions such as otitis media (middle ear infections), bronchitis, and skin infections. Severe infections are less common but can occur, especially in cases of severe neutropenia.
Diagnosis[edit]
Diagnosis of autoimmune neutropenia involves a complete blood count (CBC) to detect neutropenia. Further testing includes specific assays to detect autoantibodies against neutrophils, such as the direct antiglobulin test (DAT) or the neutrophil-specific antibody test.
Treatment[edit]
Treatment of autoimmune neutropenia is often supportive and focuses on managing infections. Antibiotics may be used to treat or prevent infections. In cases of severe neutropenia or recurrent infections, granulocyte colony-stimulating factor (G-CSF) may be administered to stimulate the production of neutrophils. In primary autoimmune neutropenia of childhood, the condition often resolves spontaneously within a few years, and treatment may not be necessary.
Prognosis[edit]
The prognosis for individuals with autoimmune neutropenia varies. In children with primary autoimmune neutropenia, the condition often resolves on its own without long-term effects. Adults with secondary autoimmune neutropenia have a prognosis that depends on the underlying condition and its management.
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian